Botulinum toxin in the treatment of lingual movement disorders

Movement Disorders

Volumn 24, Issue 15, 2009, Pages 2199-2202

  Kasravi, Neema ^a   Jog, Mandar S ^b  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b Movement Disorders Program   (Canada)

Author keywords

Botulinum toxin; Dyskinesia; Dystonia; Movement disorders; Tongue; Tremor

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; DYSPHAGIA; FEMALE; HUMAN; HYPERSALIVATION; LINGUAL MOVEMENT DISORDER; MALE; MOTOR DYSFUNCTION; PRIORITY JOURNAL; TONGUE DISEASE; TREATMENT DURATION; TREATMENT RESPONSE;

AGED; ANTI-DYSKINESIA AGENTS; ANTIPARKINSON AGENTS; BOTULINUM TOXINS; FEMALE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; MOVEMENT DISORDERS; PARKINSON DISEASE; RETROSPECTIVE STUDIES; TIME FACTORS; TONGUE DISEASES;

EID: 72849126124     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22549     Document Type: Article

References (17)

1. Papapetropoulos S, Singer C. Primary focal lingual dystonia. Mov Disord 2006;21:429-430.
2. Baik JS, Park JH, Kim JY. Primary lingual dystonia induced by speaking. Mov Disord 2004;19:1251-1252.
3. Schneider SA, Aggarwal A, Bhatt M, et al. Severe tongue protrusion dystonia: clinical syndromes and possible treatment. Neurology 2006;67:940-943.
4. Blitzer A, Brin MF, Fahn S. Botulinum toxin injections for lingual dystonia. Laryngoscope 1991;101(7 Pt 1):799.
5. Charles PD, Davis TL, Shannon KM, Hook MA, Warner JS. Tongue protrusion dystonia: treatment with botulinum toxin. South Med J 1997;90:522-525.
6. Lee KH. Oromandibular dystonia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;104:491-496.
7. Blitzer A, Brin MF, Greene PE, Fahn S. Botulinum toxin injection for the treatment of oromandibular dystonia. Ann Otol Rhinol Laryngol 1989;98:93-97.
8. Hermanowicz N, Truong DD. Treatment of oromandibular dystonia with botulinum toxin. Laryngoscope 1991;101:1216-1218.
9. Kanovsky P, Streitova H, Bares M, Hortova H. Treatment of facial and orolinguomandibular tardive dystonia by botulinum toxin A: evidence of a long-lasting effect. Mov Disord 1999;14:886-888.
10. Ishii K, Tamaoka A, Shoji S. A case of primary focal lingual dystonia induced by speaking. Eur J Neurol 2001;8:507.
11. Tan EK, Chan LL. Sensory tricks and treatment in primary lingual dystonia. Mov Disord 2005;20:388.
12. Bradley WG, Daroff RB, Fenichel GM, Jancovich J, editors. Neurology in clinical practice, 5th ed. Pennsylvania: Butterworth- Heinemann/Elsevier; 2008. 316 p.
13. Balasubramaniam R, Rasmussen J, Carlson LW, Van Sickels JE, Okeson JP. Oromandibular dystonia revisited: a review and a unique case. J Oral Maxillofac Surg 2008;66:379-386.
14. Jankovic J. Medical therapy and botulinum toxin in dystonia. Adv Neurol 1998;78:169-183.
15. Jankovic J, Hallett M, editors. Therapy with botulinum toxin. New York: M. Dekker; 1994. 433 p.
16. Hamani C, Moro E. Surgery for other movement disorders: dystonia, tics. Curr Opin Neurol 2007;20:470-476. (Pubitemid 47051996)
17. Capelle HH, Weigel R, Krauss JK. Bilateral pallidal stimulation for blepharospasm-oromandibular dystonia (Meige syndrome). Neurology 2003;60:2017-2018. (Pubitemid 36736035)